Tate group members including Prof. Tate presented their research at the BMCS postgraduate conference at the University of Oxford.
This conference organised by the Biological and Medicinal Chemistry sector of the RSC is a face-to-face meeting comprising of oral and poster presentations from PhD students and post-doctoral workers researching in the field. In addition, the talks were supported with invited keynote speakers from industry and academia.
Whilst there, Prof. Tate delivered his keynote lecture on the development of antimalarials to ADCs. The origin story and developments behind the successful Imperial Spin-out company Myricx Bio.
The talks were also concluded with poster presentations from PhD students and post-doctoral workers from the Tate group, with group member Jiaying Zhuang winning an RSC Medicinal Chemistry prize for her work on ‘An automated chemoproteomic platform for DUB and deubiquitinase inhibitor discovery”.
Congratulations to Jiaying!
Article text (excluding photos or graphics) © Imperial College London.
Photos and graphics subject to third party copyright used with permission or © Imperial College London.
Reporter
Dr Thomas J Burden
Department of Chemistry
Contact details
Tel: +44 (0)20 7594 5821
Email: t.burden@imperial.ac.uk
Show all stories by this author